Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Updates through midday U.S. trading)By David RandallNEW YORK, Dec 1 (Reuters) - Stock markets rose and safe havens such as U.S. Treasury bonds dipped Tuesday as better-than-expected factory data and signs that the first coronavirus vaccinations c...
Read more* Half-dose, full-dose could complicate vaccine distribution-SII* SII sees factors beyond efficacy as crucial in vaccine decisions* SII sees affordability, ease of storage and transport as keyBy Abhirup Roy and Euan RochaPUNE, Dec 1 (Reuters) - Se...
Read more(Adds Ohio governor, travel data)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year with expectations that promising vaccine candidates will soon be approved to halt the rapidly spreading coronavirus after 4.2 mill...
Read more(Deletes extraneous "refuse to" in 2nd paragraph)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel coronavirus aft...
Read moreBy David RandallNEW YORK, Dec 1 (Reuters) - Stock markets rose and safe havens such as U.S. Treasury bonds dipped Tuesday as better than expected factory data and signs that the first coronavirus vaccinations could be administered by the end of th...
Read more(Adds details, updates prices, changes dateline)* World shares up 0.4%, U.S. futures up sharply* Vaccine hopes drives optimism after EZ factory recovery falters* China factory activity growth hits decade high in November* U.S. dollar weakens, Bitcoi...
Read moreDHAKA, Dec 1 (Reuters) - Bangladesh expects to receive its first batch of coronavirus vaccines by February which people will receive free of charge, the health secretary said on Tuesday.The South Asian country of more than 160 million last month ...
Read more(Corrects details of vaccine approval procedure, third paragraph)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel...
Read moreWASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel coronavirus after 4.2 million new cases were reported in Novemb...
Read more* Pfizer, BioNTech request EU conditional approval* Regulator says panel to meet Dec 29 at latest* Rival Moderna also submits EU filing for its shot* Both groups have applied for U.S. emergency use (Adds review timing, details on Moderna request)By ...
Read more* Pfizer, BioNTech request EU conditional approval* Regulator says panel to meet Dec 29 at latest* Rival Moderna also submits EU filing for its shot* Both groups have applied for U.S. emergency use (Adds EMA starting rolling review of J&J candidate)...
Read more* Pfizer, BioNTech request EU conditional approval* Raises prospect of European launch this month* Rival Moderna has said it is nearing an EU filing* Pfizer-BioNTech sought U.S. emergency nod in Nov (Adds background on pandemic, companies quote)By L...
Read moreFRANKFURT, Dec 1 (Reuters) - Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.Th...
Read more
LONDON MARKET OPEN: Stocks Look To Build On Strong November Gains
Read moreAstraZeneca To Divest European Rights To Crestor To Grunenthal
Read more
Last checked at